Carbamazepine
- Product NDC
- 68084-561
- 11-digit product format
- 680840561
- Labeler code
- 68084
- Product ID
- 68084-561_d5410c8d-bcc4-ee14-e053-2995a90a8c3a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- NDA020234
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2012-01-05
- Marketing end
- 2023-06-30
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68084-561-21 | 68084056121 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-561-21) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68084-561-11) | 30 blister pack | 2012-01-05 | 0000-00-00 | No | No | Current |